StonvexLoading…
StonvexStonvexStonvexCore line items from HY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.77B | $4.31B | $4.12B | $3.55B |
Operating Income | $-22.10M | $244.80M | $208.70M | $-39.10M |
Net Income | $-60.10M | $142.30M | $125.90M | $-74.10M |
EPS (Diluted) | $-3.40 | $8.04 | $7.24 | $-4.38 |
Total Assets | $2.02B | $2.03B | $2.08B | $2.03B |
Total Liabilities | $1.53B | $1.54B | $1.67B | $1.80B |
Cash & Equivalents | $123.20M | $96.60M | $78.80M | $59.00M |
Free Cash Flow OCF − CapEx | $23.60M | $122.90M | $115.30M | $11.80M |
Shares Outstanding | 17.67M | 17.71M | 17.39M | 16.90M |